Wright Jay S, Ma Richard, McCarthy Casey J, Kaup Gina, George Emma, Priest Joshua D, Webb E William, Cheng Kevin, Bowden Gregory D, Brooks Allen F, Shao Xia, Sanford Melanie S, Scott Peter J H
Department of Radiology, University of Michigan, Ann Arbor, MI, 48109, USA.
Department of Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA.
Chem. 2025 Aug 20. doi: 10.1016/j.chempr.2025.102707.
Copper-mediated radiolabelling has transformed how (hetero)aromatic imaging agents are prepared for positron emission tomography (PET). However, current methods maintain critical stability, reactivity, and toxicity concerns paramount for safely and reproducibly generating radiomedicines. To overcome these limitations, a copper-mediated C-cyanation reaction is presented that leverages heptamethyltrisiloxanes as (hetero)aryl nucleophiles. Rapid -radiocyanation occurs in conversions surpassing related precursors, while offering stability and safety advantages. Multiple bioactive scaffolds relevant to (pre)clinical PET were labelled to showcase the broader significance of this protocol. Most notably, an automated radiosynthesis of a κ-opioid receptor antagonist currently used in clinical PET studies is reported using this method. Overall, adopting aryl silane precursors will improve radiochemical space and support the production of PET nuclear medicines.
铜介导的放射性标记已经改变了(杂)芳族成像剂用于正电子发射断层扫描(PET)的制备方式。然而,目前的方法在安全且可重复地生产放射性药物方面,仍然将关键的稳定性、反应性和毒性问题置于首位。为了克服这些限制,本文提出了一种铜介导的C-氰化反应,该反应利用七甲基三硅氧烷作为(杂)芳基亲核试剂。快速的放射性氰化反应在转化率超过相关前体的情况下发生,同时具有稳定性和安全性优势。对多种与(临床前)临床PET相关的生物活性支架进行了标记,以展示该方案更广泛的意义。最值得注意的是,本文报道了使用该方法对目前临床PET研究中使用的κ-阿片受体拮抗剂进行自动化放射性合成。总体而言,采用芳基硅烷前体将改善放射化学空间,并支持PET核药物的生产。